PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
cebpa | dr11_v1_chr7_-_38087865_38087865 | 0.19 | 6.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_50147948 Show fit | 65.68 |
ENSDART00000149010
|
haptoglobin |
|
chr22_-_26236188 Show fit | 44.57 |
ENSDART00000162640
ENSDART00000167169 ENSDART00000138595 |
complement component c3b, tandem duplicate 1 |
|
chr5_-_63509581 Show fit | 43.76 |
ENSDART00000097325
|
complement component 5 |
|
chr1_+_59067978 Show fit | 39.81 |
ENSDART00000172613
|
si:ch1073-110a20.7 |
|
chr8_-_39739627 Show fit | 37.27 |
ENSDART00000135422
ENSDART00000067844 |
si:ch211-170d8.5 |
|
chr8_-_13972626 Show fit | 36.30 |
ENSDART00000144296
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
chr15_+_28202170 Show fit | 34.87 |
ENSDART00000077736
|
vitronectin a |
|
chr14_+_21107032 Show fit | 34.64 |
ENSDART00000138319
ENSDART00000139103 ENSDART00000184735 |
aldolase b, fructose-bisphosphate |
|
chr1_+_10051763 Show fit | 33.89 |
ENSDART00000011701
|
fibrinogen beta chain |
|
chr9_-_32847642 Show fit | 33.02 |
ENSDART00000121506
|
hemopexin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 66.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
4.6 | 63.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
3.1 | 50.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 43.9 | GO:0006955 | immune response(GO:0006955) |
6.8 | 40.7 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
12.1 | 36.3 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
1.3 | 35.1 | GO:0051180 | vitamin transport(GO:0051180) |
6.8 | 34.2 | GO:0019483 | beta-alanine metabolic process(GO:0019482) beta-alanine biosynthetic process(GO:0019483) |
0.0 | 34.1 | GO:0006508 | proteolysis(GO:0006508) |
0.4 | 31.2 | GO:0072376 | complement activation(GO:0006956) protein activation cascade(GO:0072376) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 427.2 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 125.8 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 110.1 | GO:0005739 | mitochondrion(GO:0005739) |
21.3 | 63.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 48.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 46.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 29.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
2.3 | 22.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 18.4 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 16.0 | GO:0030027 | lamellipodium(GO:0030027) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 205.1 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
8.3 | 66.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 64.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 42.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.4 | 37.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 36.8 | GO:0003823 | antigen binding(GO:0003823) |
1.6 | 33.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.6 | 32.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 31.1 | GO:0005102 | receptor binding(GO:0005102) |
10.3 | 30.8 | GO:0005499 | vitamin D binding(GO:0005499) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 81.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.8 | 80.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 66.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 58.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 19.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 15.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 11.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 7.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 6.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 5.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 66.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
5.3 | 63.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
4.2 | 54.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.9 | 50.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.6 | 34.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.1 | 29.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
2.3 | 22.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.9 | 20.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
3.6 | 17.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 14.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |